Prenatal and early life arsenic exposure induced oxidative damage and altered activities and mRNA expressions of neurotransmitter metabolic enzymes in offspring rat brain

Journal of Biochemical and Molecular Toxicology

Volumn 24, Issue 6, 2010, Pages 368-378

  Xi, Shuhua ^a   Guo, Li ^b   Qi, Rong ^b   Sun, Wenjuan ^b   Jin, Yaping ^a   Sun, Guifan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG MEDICAL COLLEGE   (China)

Author keywords

aminobutyric acid transferase; Acetylcholinesterase; Glutamate decarboxylase; Oxidative stress; Prenatal; Sodium arsenite

Indexed keywords

ACETYLCHOLINESTERASE; ARSENIC; ARSENITE SODIUM; GLUTAMATE DECARBOXYLASE; GLUTATHIONE; MALONALDEHYDE; MESSENGER RNA; NEUROTRANSMITTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; EARLY LIFE STRESS; ENZYME ACTIVITY; FEMALE; FETUS; GESTATIONAL AGE; HIPPOCAMPUS; NEWBORN; NEWBORN PERIOD; NONHUMAN; OXIDATIVE STRESS; PERINATAL PERIOD; PRENATAL EXPOSURE; PROGENY; RAT;

ACETYLCHOLINESTERASE; ANIMALS; ARSENIC; CEREBRAL CORTEX; FEMALE; HIPPOCAMPUS; MALE; MALONDIALDEHYDE; MATERNAL EXPOSURE; NEUROTRANSMITTER AGENTS; OXIDATIVE STRESS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RNA, MESSENGER; SYNAPTIC TRANSMISSION;

RATTUS;

EID: 78650451060     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20349     Document Type: Article

References (62)

1. Chhuttani PN, Chawla LS, Sharma TD. Arsenical neuropathy. Neurology 1967;17:269-274.
2. Feldman RG, Niles CA, Kelly-Hayes M, Sax DS, Dixon WJ, Thompson DJ, Landau E. Peripheral neuropathy in arsenic smelter workers. Neurology 1979;29:939-944.
3. Gerr F, Letz R, Ryan PB, Green RC. Neurological effects of environmental exposure to arsenic in dust and soil among humans. NeuroToxicology 2000;21:475-487.
4. Kreiss K, Zack MM, Landrigan PJ, Feldman RG, Niles CA, Chirico-Post J, Sax DS, Boyd MH, Cox DH. Neurologic evaluation of a population exposed to arsenic in Alaskan well water. Arch Environ Health 1983;38:116-121.
5. Murphy MJ, Lyon LW, Taylor JW. Subacute arsenic neuropathy: clinical and electrophysiological observations. J Neurol Neurosurg Psychiatry 1981;44:896-900.
6. Oh SJ. Electrophysiological profile in arsenic neuropathy. J Neurol Neurosurg Psychiatry 1991;54:1103-1105.
7. Ostrowski SR, Wilbur S, Chou CH, Pohl HR, Stevens YW, Allred PM, Roney N, Fay M, Tylenda CA. Agency for toxic substances and disease registry's 1997 priority list of hazardous substances. Latent effects carcinogenesis, neurotoxicology, and developmental deficits in humans and animals. Toxicol Ind Health 1999;15:602-644.
8. Beckett WS, Moore JL, Keogh JP, Bleecker ML. Acute encephalopathy due to occupational exposure to arsenic. Br J Ind Med 1986;43:66-67.
9. Calderon J, Navarro ME, Jimenez-Capdeville ME, Santos-Diaz MA, Golden A, Rodriguez-Leyva I, Borja-Aburto V, Diaz-Barriga F. Exposure to arsenic and lead and neuropsychological development in Mexican children. Environ Res 2001;85:69-76.
10. Danan M, Dally S, Conso F. Arsenic-induced encephalopathy. Neurology 1984;34:1524.
11. Fincher RM, Koerker RM. Long-term survival in acute arsenic encephalopathy. Follow-up using newer measures of electrophysiologic parameters. Am J Med 1987;82:549-552.
12. Franzblau A, Lilis R. Acute arsenic intoxication from environmental arsenic exposure. Arch Environ Health 1989;44:385-390.
13. Morton WE, Caron GA. Encephalopathy: an uncommon manifestation of workplace arsenic poisoning? Am J Ind Med 1989;15:1-5.
14. Bencko V, Symon K. Test of environmental exposure to arsenic and hearing changes in exposed children. Environ Health Perspect 1977;19:95-101.
15. Bolla-Wilson K, Bleecker ML. Neuropsychological impairment following inorganic arsenic exposure. J Occup Med 1987;29:500-503.
16. Tsai SY, Chou HY, The HW, Chen CM, Chen CJ. The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology 2003;24:747-753.
17. Rosado JL, Ronquillo D, Kordas K, Rojas O, Alatorre J, Lopez P, Garcia-Vargas G, Del Carmen Caamano M, Cebrian ME, Stoltzfus RJ. Arsenic exposure and cognitive performance in Mexican schoolchildren. Environ Health Perspect 2007;115:1371-1375.
18. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, van Geen A, Slavkovich V, Lolacono NJ, Cheng Z, Hussain I, Momotaj H, Graziano JH. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect 2004;112:1329-1333.
19. Wright RO, Amarasiriwardena C, Woolf AD, Jim R, Bellinger DC. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology 2006;27:210-216.
20. Chattopadhyay S, Bhaumik S, Nag Chaudhury A, Das Gupta S. Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicol Lett 2002;128:73-84.
21. Rodriguez VM, Carrizales L, Jimenez-Capdeville ME, Dufour L, Giordano M. The effects of sodium arsenite exposure on behavioral parameters in rats. Brain Res Bull 2001;55:301-308.
22. Rodriguez VM, Carrizales L, Mendoza MS, Fajardo OR, Giordano M. Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicol Teratol 2002;24:743-750.
23. Schulz H, Nagymajtenyi L, Institoris L, Papp A, Siroki O. A study on behavioral, neurotoxicological, and immunotoxicological effects of subchronic arsenic treatment in rats. J Toxicol Environ Health A 2002;65:1181-1193.
24. Itoh T, Zhang YF, Murai S, Saito H, Nagahama H, Miyate H, Saito Y, Abe E. The effect of arsenic trioxide on brain monoamine metabolism and locomotor activity of mice. Toxicol Lett 1990;54:345-353.
25. Nagaraja TN, Desiraju T. Effects on operant learning and brain acetylcholine esterase activity in rats following chronic inorganic arsenic intake. Hum Exp Toxicol 1994;13:353-356.
26. Xi S, Sun W, Wang F, Jin Y., Sun G. Transplacental and early life exposure to inorganic arsenic affected development and behavior in offspring rats. Arch Toxicol 2009;83:549-556.
27. Delgado JM, Dufour L, Grimaldo JI, Carrizales L, Rodríguez VM, Jiménez-Capdeville ME. Effects of arsenite on central monoamines and plasmatic levels of adrenocorticotropic hormone (ALTH) in mice. Toxicl Lett 2000;117:61-67.
28. Jana K, Jana S, Samanta PK. Effects of chronic exposure to sodium arsenite on hypothalamo-pituitary-testicular activities in adult rats: possible an estrogenic mode of action. Reprod Biol Endocrinol 2006;16: 4-9.
29. Kobayashi H, Yuyama A, Ishihara M, Matsusaka N. Effects of arsenic on cholinergic parameters in brain in vitro. Neuropharmacology 1987;26:1703-1713.
30. Mejia JJ, Diaz-Barriga F, Calderon J, Rios C, Jimenez-Capdeville ME. Effects of lead-arsenic combined exposure on central monoaminergic systems. Neurotoxicol Teratol 1997;19:489-497.
31. Nagaraja TN, Desiraju T. Regional alterations in the levels of brain biogenic amines, glutamate, GABA, and GAD activity due to chronic consumption of inorganic arsenic in developing and adult rats. Bull Environ Contam Toxicol 1993;50:100-107.
32. Tripathi N, Kannan GM, Pant BP, Jaiswal DK, Malhotra PR, Flora SJ. Arsenic-induced changes in certain neurotransmitter levels and their recoveries following chelation in rat whole brain. Toxicol Lett 1997;92:201-208.
33. Valkonen S, Savolainen H, Jarvisalo J. Arsenic distribution and neurochemical effects in peroral sodium arsenite exposure of rats. Bull Environ Contam Toxicol 1983;30:303-308.
34. Zarazua S, Perez-Severiano F, Delgado JM, Martinez LM, Ortiz-Perez D, Jimenez-Capdeville ME. Decreased nitric oxide production in the rat brain after chronic arsenic exposure. Neurochem Res 2006;31:1069-1077.
35. Garcia-Chávez E, Santamaria A, Diaz-Barriga F, Mandeville P, Juarez BI, Jiménez-Capdeville ME. Arsenite-induced formation of hydroxyl radical in the striatum of awake rats. Brain Res 2003;976:82-89.
36. Kato K, Mizoi M, An Y, Nakano M, Wanibuchi H, Endo G, Endo Y, Hoshino M, Okada S, Yamanaka K. Oral administration of diphenylarsinic acid, a degradation product of chemical warfare agents, induces oxidative and nitrosative stress in cerebellar Purkinje cells. Life Sci 2007;81:1518-1525.
37. Modi M, Flora SJ. Combined administration of iron and monoisoamyl-DMSA in the treatment of chronic arsenic intoxication in mice. Cell Biol Toxicol 2007;23:429-443.
38. Rao MV, Avani G. Arsenic induced free radical toxicity in brain of mice. Indian J Exp Biol 2004;42:495-498.
39. Rodriguez VM, Del Razo LM, Limon-Pacheco JH, Giordano M, Sanchez-Pena LC, Uribe-Querol E, Gutierrez-Ospina G, Gonsebatt ME. Glutathione reductase inhibition and methylated arsenic distribution in CD1 mice brain and liver. Toxicol Sci 2005;84:157-166.
40. Jin Y, Xi S, Li X, Lu C, Li G, Xu Y, Qu C, Niu Y, Sun G. Arsenic speciation transported through the placenta from mother mice to their newborn pups. Environ Res 2006;101:349-355.
41. Xi S, Jin Y, Lv X, Sun G. Distribution and speciation of arsenic by transplacental and early life exposure to inorganic arsenic in offspring rats. Biol Trace Elem Res 2010;134:84-97.
42. Hood RD, Vedel-Macrander GC, Zaworotko MJ, Tatum FM, Meeks RG. Distribution, metabolism, and fetal uptake of pentavalent arsenic in pregnant mice following oral or intraperitoneal administration. Teratology 1987;35:19-25.
43. Hood RD, Vedel GC, Zaworotko MJ, Tatum FM, Meeks RG. Uptake, distribution, and metabolism of trivalent arsenic in the pregnant mouse. J Toxicol Environ Health 1988;25:423-434.
44. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-310.
45. Flohe L, Gunzler WA. Assays of glutathione peroxidase. Meth Enzymol 1984;105:114-121.
46. Renis M, Cardile V, Russo A, Campisi A, Collova F. Glutamine synthetase activity and HSP70 levels in cultured rat astrocytes: effect of 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. Brain Res 1998;783:143-150.
47. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
48. Flora SJ, Mittal M, Mishra D. Co-exposure to arsenic and fluoride on oxidative stress, glutathione linked enzymes, biogenic amines and DNA damage in mouse brain. J Neurol Sci 2009;285:198-205.
49. García-Chávez E, Jiménez I, Segura B, Del Razo LM. Lipid oxidative damage and distribution of inorganic arsenic and its metabolites in the rat nervous system after arsenite exposure: influence of alpha tocopherol supplementation. Neurotoxicology 2006;27:1024-1031.
50. Das S, Santra A, Lahiri S, Guha Mazumder DN. Implications of oxidative stress and hepatic cytokine (TNF-alpha and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity. Toxicol Appl Pharmaco 2005;204:18-26.
51. Bhadauria S, Flora SJ. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats. Cell Biol Toxicol 2007;23:91-104.
52. Kannan GM, Flora SJ. Chronic arsenic poisoning in the rat: treatment with combined administration of succimers and an antioxidant. Ecotoxicol Environ Saf 2004;58:37-43.
53. Patlolla AK, Tchounwou PB. Serum acetyl cholinesterase as a biomarker of arsenic induced neurotoxicity in Sprague-Dawley rats. Int J Environ Res Public Health 2005;2:80-83.
54. Zhang SS, Zhang L, Zhang DS. The regulation system of Glu/GABA on learning and memory in brain. Acta Pharma Sinica 1997;32:638-640 (in Chinese).
55. Had-Aissouni L, Re DB, Nieoullon A, Kerkerian-Le Goff L. Importance of astrocytic inactivation of synaptically released glutamate for cell survival in the central nervous system-are astrocytes vulnerable to low intracellular glutamate concentrations? J Physiol Paris 2002;96:317-322.
56. Akbarian S, Huang HS. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 2006;52:293-304.
57. Esclapez M, Tillakaratne NJ, Kaufman DL, Tobin AJ, Houser CR. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J Neurosci 1994;14:1834-1855.
58. Houser CR, Esclapez M. Localization of mRNAs encoding two forms of glutamic acid decarboxylase in the rat hippocampal formation. Hippocampus 1994;4:530-545.
59. Dupuy ST, Houser CR. Prominent expression of two forms of glutamate decarboxylase in the embryonic and early postnatal rat hippocampal formation. J Neurosci 1996;16:6919-6932.
60. Satyanarayan V, Nair PM. Purification and characterization of glutamate decarboxylase from Solanum tuberosum. Eur J Biochem 1985;150:53-60.
61. Solimena M, Aggujaro D, Muntzel C, Dirkx R, Butler M, De Camilli P, Hayday A. Association of GAD-65, but not of GAD-67, with the Golgi complex of transfected Chinese hamster ovary cells mediated by the N-terminal region. Proc Natl Acad Sci USA 1993;90:3073-3077.
62. Labiner DM, Yan CC, Weinand ME, Huxtable RJ. Disturbances of amino acids from temporal lobe synaptosomes in human complex partial epilepsy. Neurochem Res 1999;24:1379-1383.